Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population | Nature Medicine
PolitiFact | Instagram post misleads on vaccine efficacy by conflating two different measures
Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ
Relative risk reduction: Misinformative measure in clinical trials and COVID-19 vaccine efficacy - ScienceDirect
Testing fractional doses of COVID-19 vaccines | PNAS
Pfizer Vaccine Efficacy Explained - Coronavirus News - YouTube
VERIFY: Why is absolute risk reduction in COVID-19 vaccines smaller than relative risk reduction? - YouTube
Medicina | Free Full-Text | Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials
Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines | NEJM
Full article: Efficacy and effectiveness of covid-19 vaccine - absolute vs. relative risk reduction
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant | NEJM
Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study | The BMJ
Muddled-up data misleads on COVID-19 vaccine efficacy - Australian Associated Press
Absolute risk reduction formula vs. Relative risk reduction | wusa9.com
Understanding and Communicating about COVID-19 Vaccine Efficacy, Effectiveness, and Equity | Understanding and Communicating about COVID-19 Vaccine Efficacy, Effectiveness, and Equity |The National Academies Press
Vaccines | Free Full-Text | The Safety of COVID-19 Vaccinations—We Should Rethink the Policy
Relative risk reduction: Misinformative measure in clinical trials and COVID-19 vaccine efficacy - ScienceDirect
The Daily Herald - Why Relative Risk Reduction, not Absolute Risk Reduction, is most often used in calculating vaccine efficacy
Benefit of COVID-19 vaccination accounting for potential risk compensation | npj Vaccines
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants | Nature Communications
Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant | Science
Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination | Nature Communications
Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study - The Lancet Respiratory Medicine
Efficacy of live attenuated and inactivated influenza vaccines among children in rural India: A 2-year, randomized, triple-blind, placebo-controlled trial | PLOS Medicine
A Covid-19 Milestone Attained — A Correlate of Protection for Vaccines | NEJM
Medicina | Free Full-Text | Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials
